Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood

Addictive Behaviors

Volumn 38, Issue 11, 2013, Pages 2683-2689

  Lee, Chien Ti ^a   Fuemmeler, Bernard F ^a   McClernon, F Joseph ^a,b   Ashley Koch, Allison ^a   Kollins, Scott H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

ADHD; NAChR SNPs; Smoking development

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BETA3; UNCLASSIFIED DRUG;

ADOLESCENCE; ADULTHOOD; ARTICLE; ATTENTION DEFICIT DISORDER; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LONGITUDINAL STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYMPTOM;

ADHD; NACHR SNPS; SMOKING DEVELOPMENT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; GENOTYPE; HUMANS; MALE; NATIONAL LONGITUDINAL STUDY OF ADOLESCENT HEALTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; SMOKING; YOUNG ADULT;

EID: 84881260616     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2013.06.013     Document Type: Article

References (46)

1. Audrain-McGovern J., Lerman C., Wileyto E.P., Rodriguez D., Shields P.G. Interacting effects of genetic predisposition and depression on adolescent smoking progression. The American Journal of Psychiatry 2004, 161(7):1224-1230.
2. Bidwell L.C., Garrett M.E., McClernon F.J., Fuemmeler B.F., Williams R.B., Ashley-Koch A.E., et al. A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults. Nicotine & Tobacco Research 2012, 14(2):229-233.
3. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Human Molecular Genetics 2007, 16(1):24-35.
4. Duncan S.C., Duncan T.E., Strycker L.A., Chaumeton N.R. A cohort-sequential latent growth model of physical activity from ages 12 to 17years. Annals of Behavioral Medicine 2007, 33(1):80-89.
5. Duncan L.E., Keller M.C. A critical review of the first 10years of candidate gene-by-environment interaction research in psychiatry. The American Journal of Psychiatry 2011, 168(10):1041-1049.
6. Freeman B., Powell J., Ball D., Hill L., Craig I., Plomin R. DNA by mail: An inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behavior Genetics 1997, 27(3):251-257.
7. Fuemmeler B.F., Kollins S.H., McClernon F.J. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. Journal of Pediatric Psychology 2007, 32(10):1203-1213.
8. Graffelman J., Camarena J.M. Graphical tests for Hardy-Weinberg equilibrium based on the ternary plot. Human Heredity 2008, 65(2):77-84.
9. Greenbaum L., Kanyas K., Karni O., Merbl Y., Olender T., Horowitz A., et al. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Molecular Psychiatry 2006, 11(3):312-322. (223).
10. Greenbaum L., Lerer B. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: Recent progress and emerging open questions. Molecular Psychiatry 2009, 14(10):912-945.
11. Harris K.M., Halpern C.T., Whitsel E., Hussey J., Tabor J., Entzel P., et al. The National Longitudinal Study of Adolescent Health: Research Design from. http://www.cpc.unc.edu/projects/addhealth/design.
12. Hoft N.R., Corley R.P., McQueen M.B., Schlaepfer I.R., Huizinga D., Ehringer M.A. Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample. Neuropsychopharmacology 2009, 34(3):698-706.
13. Holmbeck G.N. Post-hoc probing of significant moderational and mediational effects in studies of pediatric populations. Journal of Pediatric Psychology 2002, 27(1):87-96.
14. Humfleet G.L., Prochaska J.J., Mengis M., Cullen J., Munoz R., Reus V., et al. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder and smoking treatment failure. Nicotine & Tobacco Research 2005, 7(3):453-460.
15. Kent L., Middle F., Hawi Z., Fitzgerald M., Gill M., Feehan C., et al. Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatric Genetics 2001, 11(1):37-40.
16. Kollins S.H., McClernon F.J., Fuemmeler B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Archives of General Psychiatry 2005, 62(10):1142-1147.
17. Lench N., Stanier P., Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet 1988, 1(8599):1356-1358.
18. Lerman C., Audrain J., Tercyak K., Hawk L.W., Bush A., Crystal-Mansour S., et al. Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine & Tobacco Research 2001, 3(4):353-359.
19. Lerman C., Caporaso N.E., Audrain J., Main D., Boyd N.R., Shields P.G. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence. Molecular Psychiatry 2000, 5(2):189-192.
20. Lerman C., Shields P.G., Wileyto E.P., Audrain J., Hawk L.H., Pinto A., et al. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Health Psychology 2003, 22(5):541-548.
21. Li D.W., Sham P.C., Owen M.J., He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Human Molecular Genetics 2006, 15(14):2276-2284.
22. Liu H., Powers D.A. Growth curve models for zero-inflated count data: An application to smoking behavior. Structural Equation Modeling: A Multidisciplinary Journal 2007, 14(2):247-279.
23. McClernon F.J., Fuemmeler B.F., Kollins S.H., Kail M.E., Ashley-Koch A.E. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. Nicotine & Tobacco Research 2008, 10(1):117-127.
24. McClernon F.J., Van Voorhees E.E., English J., Hallyburton M., Holdaway A., Kollins S.H. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: Results from a 12-day contingency-managed abstinence trial. Nicotine & Tobacco Research 2011, 13(9):784-792.
25. Meulenbelt I., Droog S., Trommelen G.J., Boomsma D.I., Slagboom P.E. High-yield noninvasive human genomic DNA isolation method for genetic studies in geographically dispersed families and populations. American Journal of Human Genetics 1995, 57(5):1252-1254.
26. Milberger S., Biederman J., Faraone S.V., Chen L., Jones J. ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 1997, 36(1):37-44.
27. Molina B.S.G., Pelham W.E. Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. Journal of Abnormal Psychology 2003, 112(3):497-507.
28. Murphy K., Barkley R.A. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: Implications for clinical diagnosis. Journal of Attention Disorders 1996, 1(3):147-161.
29. Muthén L.K., Muthén B.O. Mplus User's Guide 1998-2011, Muthén & Muthén, Los Angeles, CA. 6th ed.
30. Resnick M.D., Bearman P.S., Blum R.W., Bauman K.E., Harris K.M., Jones J., et al. Protecting adolescents from harm - Findings from the National Longitudinal Study on Adolescent Health. JAMA : The Journal of the American Medical Association 1997, 278(10):823-832.
31. Rigbi A., Kanyas K., Yakir A., Greenbaum L., Pollak Y., Ben-Asher E., et al. Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes, Brain, and Behavior 2008, 7(2):164-172.
32. Rohde P., Kahler C.W., Lewinsohn P.M., Brown R.A. Psychiatric disorders, familial factors, and cigarette smoking: II. Associations with progression to daily smoking. Nicotine & Tobacco Research 2004, 6(1):119-132.
33. Russo P., Cesario A., Rutella S., Veronesi G., Spaggiari L., Galetta D., et al. Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment. Current Medicinal Chemistry 2011, 18(1):91-112.
34. Spitz M.R., Shi H., Yang F., Hudmon K.S., Jiang H., Chamberlain R.M., et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. Journal of the National Cancer Institute 1998, 90(5):358-363.
35. Stevens V.L., Bierut L.J., Talbot J.T., Wang J.C., Sun J., Hinrichs A.L., et al. Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiology, Biomarkers & Prevention 2008, 17(12):3517-3525.
36. Tercyak K.P., Lerman C., Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41(7):799-805.
37. Todd R.D., Lobos E.A., Sun L.W., Neuman R.J. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: Evidence for association of an intronic polymorphism with attention problems. Molecular Psychiatry 2003, 8(1):103-108.
38. Volkow N.D., Wang G.J., Kollins S.H., Wigal T.L., Newcorn J.H., Telang F., et al. Evaluating dopamine reward pathway in ADHD: Clinical implications. Journal of the American Medical Association 2009, 302(10):1084-1091.
39. Volkow N.D., Wang G.J., Newcorn J.H., Kollins S.H., Wigal T.L., Telang F., et al. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway. Molecular Psychiatry 2011, 16(11):1147-1154.
40. Wallis D., Arcos-Burgos M., Jain M., Castellanos F.X., Palacio J.D., Pineda D., et al. Polymorphisms in the neural nicotinic acetylcholine receptor alpha4 subunit (CHRNA4) are associated with ADHD in a genetic isolate. Attention Deficit and Hyperactivity Disorders 2009, 1(1):19-24.
41. Ware J.J., van den Bree M.B., Munafo M.R. Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: A meta-analysis. Nicotine & Tobacco Research 2011, 13(12):1167-1175.
42. Winterer G., Mittelstrass K., Giegling I., Lamina C., Fehr C., Brenner H., et al. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. American Journal of Medical Genetics 2010, 153B:1448-1458.
43. Winterer G., Musso F., Konrad A., Vucurevic G., Stoeter P., Sander T., et al. Association of attentional network function with exon 5 variations of the CHRNA4 gene. Human Molecular Genetics 2007, 16(18):2165-2174.
44. Zeiger J.S., Haberstick B.C., Schlaepfer I., Collins A.C., Corley R.P., Crowley T.J., et al. The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Human Molecular Genetics 2008, 17(5):724-734.
45. Zhang L., Cui X., Schmitt K., Hubert R., Navidi W., Arnheim N. Whole genome amplification from a single cell: Implications for genetic analysis. Proceedings of the National Academy of Sciences of the United States of America 1992, 89(13):5847-5851.
46. Zhang H., Kranzler H.R., Poling J., Gelernter J. Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility. Neuropsychopharmacology 2010, 35:2211-2224.